PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis.
about
Molecular prognostic prediction in liver cirrhosisAssociation between PNPLA3 rs738409 polymorphisms and risk of hepatocellular carcinoma and its development in patients with cirrhosis: a meta-analysisPrediction models of hepatocellular carcinoma development in chronic hepatitis B patientsLipid dysregulation in hepatitis C virus, and impact of statin therapy upon clinical outcomesPNPLA3 I148M associations with liver carcinogenesis in Japanese chronic hepatitis C patients.Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta-analysis of individual participant data.Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease.Systems biology for hepatologists.Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.Host genetics predict clinical deterioration in HCV-related cirrhosis.PNPLA3 I148M polymorphism, clinical presentation, and survival in patients with hepatocellular carcinomaPNPLA3 Gene Polymorphism Is Associated With Predisposition to and Severity of Alcoholic Liver Disease.Association of PNPLA3 I148M Variant With Chronic Viral Hepatitis, Autoimmune Liver Diseases and Outcomes of Liver TransplantationPNPLA3 genetic variation in alcoholic steatosis and liver disease progression.Role of genetic polymorphisms in hepatitis C virus chronic infection.Development and Internal Validation of a Model for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis.Insights from Genome-Wide Association Analyses of Nonalcoholic Fatty Liver Disease.Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review.Primary liver injury and delayed resolution of liver stiffness after alcohol detoxification in heavy drinkers with the PNPLA3 variant I148M.Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment.The association of variants in PNPLA3 and GRP78 and the risk of developing hepatocellular carcinoma in an Italian population.Update on biomarkers of hepatocellular carcinoma.The effect of PNPLA3 on fibrosis progression and development of hepatocellular carcinoma: a meta-analysis.Systematic review with meta-analysis: the I148M variant of patatin-like phospholipase domain-containing 3 gene (PNPLA3) is significantly associated with alcoholic liver cirrhosis.Host genetic variants influencing the clinical course of hepatitis C virus infection.Constitutional and functional genetics of human alcohol-related hepatocellular carcinoma.Nonalcoholic fatty liver disease in Asia: emerging perspectives.PNPLA3 polymorphism increases risk for and severity of chronic hepatitis C liver disease.Tailored algorithms for hepatocellular carcinoma surveillance: Is one-size-fits-all strategy outdated?Combination of PNPLA3 and TLL1 polymorphism can predict advanced fibrosis in Japanese patients with nonalcoholic fatty liver disease.Significant Association Between Adiponutrin and Hepatocellular Carcinoma Risk.Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine.Impact of PNPLA3 polymorphisms on the development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.Misdiagnosis of hepatocellular carcinoma in patients receiving no local-regional therapy prior to liver transplant: An analysis of the Organ Procurement and Transplantation Network explant pathology form.Interaction and joint effect of ALT and chronic liver disease on liver cancer in type 2 diabetes patients.Alcohol and Hepatocellular Carcinoma: Adding Fuel to the Flame.Host genetic variations associated with disease progression in chronic hepatitis C virus infection.Development of hepatocellular carcinoma in Japanese patients with biopsy-proven non-alcoholic fatty liver disease: Association between PNPLA3 genotype and hepatocarcinogenesis/fibrosis progression.
P2860
Q26784251-85E99EBA-DBB6-4A24-8453-0C729377AB43Q26801941-CC5679BC-5287-4CAD-9B6F-DE4520ECC3C4Q28066959-DC321021-A1DA-4A7D-A283-4EA944205B52Q28081216-CFB4D2FA-FCA4-4287-BBA5-7030AB62095FQ30418176-156744B9-0BCB-4886-993B-9AD8CA3FCDACQ30675355-C16AE652-38B0-4345-AEC5-30E457A4EBF5Q33886948-C87CC090-65EC-434F-A8DF-C656AE262B69Q33927426-236290EE-C819-44B4-B410-305F6AA00E5DQ34255487-17F03091-EF1D-47BF-B31F-2A09E0DCB3C1Q34689664-694E9ABA-B178-4D4B-A2FC-A8AD9DA95536Q35025215-CADAB3E7-50AA-4F16-BD29-72DB9E491CB0Q35627657-C3CB1FAC-F1B0-45B3-899B-3F19D3E6706BQ35667877-4AFDCAD4-D143-4BEF-A1D0-3F83E5BDDB6FQ35737438-A21FAB24-0786-4050-87F9-1CBDF568C1D2Q35779058-2C97DE6F-0240-4DDD-9E43-96AE38A71434Q36404471-A6F0E883-8C73-45D3-B9E3-F2B15A2D7354Q37087800-4A682CC4-765F-49BA-BBA5-CC47ADB7F8B8Q37146192-323C079B-88EA-4900-87FD-C92B54FCFF27Q37513088-C1EFFC1C-F2CA-46BF-BC09-64EEF70E11E6Q37584311-BDCCE700-5BC3-418F-A882-81046659A836Q37699335-93E30C9E-48AA-4379-88B2-4EBBF5E3A4DEQ38166133-DD15791E-A1D5-4D4F-9DAE-3FDE3475B56DQ38180333-4E5776F4-FE67-401F-8ED2-2C7055EE10B3Q38233721-ABF6E457-08EE-4E4C-B57A-04EB07E4185CQ38554500-63A78725-6CE8-40F7-81B0-9219477A4D68Q38906439-BF3129FC-5CF9-4BEC-96FF-8BFBBD620646Q38956717-DB515660-B4FC-44C1-AFB8-660D5454CD39Q39041976-C6CF0118-09D9-4BBA-B07E-86F3E2D171F8Q39197775-B69574DD-D961-4B89-840C-D6FD807E9FEDQ40108180-9B90AD07-D45E-4617-95B9-D61D3617FC82Q40246676-141D302E-5636-4BB0-80B9-81B732E3D6C9Q41921861-47A985EE-422D-4853-8AF7-6BD6B502FEFDQ42262540-E974E9BB-0A94-47AE-8E44-4906C66A9310Q42688811-CB150560-3C75-439B-834F-8F9CC1752D12Q47097925-C2122E7E-A5DE-47F5-B8B5-617E4CFF3898Q47165536-2EC2D1DA-E8B3-42EF-81A2-DB86302D2F4CQ47566385-738635FA-74F8-4FAC-AA8D-F95242B173BAQ53551272-FB7F780D-7D36-4D62-9CC0-8C1D91EDCB7D
P2860
PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
PNPLA3 rs738409, hepatocellula ...... on in patients with cirrhosis.
@en
PNPLA3 rs738409, hepatocellula ...... on in patients with cirrhosis.
@nl
type
label
PNPLA3 rs738409, hepatocellula ...... on in patients with cirrhosis.
@en
PNPLA3 rs738409, hepatocellula ...... on in patients with cirrhosis.
@nl
prefLabel
PNPLA3 rs738409, hepatocellula ...... on in patients with cirrhosis.
@en
PNPLA3 rs738409, hepatocellula ...... on in patients with cirrhosis.
@nl
P2093
P50
P1476
PNPLA3 rs738409, hepatocellula ...... ion in patients with cirrhosis
@en
P2093
Jean-Claude Trinchet
Michel Beaugrand
Pierre Rufat
P304
P356
10.1016/J.JHEP.2012.09.036
P50
P577
2012-10-13T00:00:00Z